Abstract
Artificial intelligence (AI) may be an additional catalytic instrument to manage several diseases and disorders. This review article aims to address the significant intervention of AI to manage fertility-associated clinical symptoms. Several challenges in pregnancy research lie in the necessity to consider the welfare and interests of fertile parents. In addition to that, there are several challenges to developing, designing and delivering the new drugs intended for pregnant women. Some of the AI tools perform specific subtasks within the clinical trial design process to enhance the overall performance of clinical trials. Thus, by adhering to the AI approach which can be gradually integrated into the clinical trial ecosystem. This review has also examined the difficulties that emerge when conducting trials that are intended for use during pregnancy and childhood and further, AI techniques can act as potential strategies for mitigating adverse drug reactions during trial sessions. However, Various ethical and regulatory guidelines are set up for effective trial management.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
